Clinical and Economic Implications of Genetic Testing for Warfarin Management

Completed · Phase 4

Conditions studied: Blood Coagulation Disorders

In brief

The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether providing doctors with data on the genes their patients inherited and warfarin dosing recommendations based on those genes affects the costs and outcomes of care and after hospitalization for patients from different ethnic/racial backgrounds, and how physicians use this information in decision making.

Key facts

Study ID

NCT00964353

Run by

University of Chicago

People needed

359

Starts

2009-08-01

Expected to finish

2014-04-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• warfarin-naive patients
• ages 18 and older
• are undergoing inpatient anticoagulation initiation with warfarin for diagnoses that necessitate anticoagulation

You may not qualify if…

• patients who are not warfarin-naive
• 17 years of age or younger

Where it is running

• University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.